Loading...
Loading...
Moderna Inc MRNA shares are trading higher by 4.7% at $165.44 Thursday afternoon after a Japan health panel recommended approval of the company's COVID-19 vaccine.
Moderna is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in